Transcriptomics

Dataset Information

0

Systems biology analysis unravels complementary action of combined Rosuvastatin and Ezetimibe therapy


ABSTRACT: Transcriptomics analysis to understand both efficacy and side effects of a cholesterol lowering drug combination therapy based on biological pathways and molecular processes affected by each drug alone or in combination. We have treated ApoE*3Leiden mice, a humanized atherosclerosis model with a unique human-like response to cholesterol-lowering drugs, with RSV and EZE alone and in combination. We demonstrate that processes affected by monotherapy can be retained and enhanced by combination therapy. In addition, combination therapy also affects a number of processes which are not predictable on basis of monotherapy – at least when analysis is performed within the borders of statistical significance. Our data however provide clues for these “non-predictable” effects.

ORGANISM(S): Mus musculus

PROVIDER: GSE38688 | GEO | 2013/02/27

SECONDARY ACCESSION(S): PRJNA168440

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-02-27 | E-GEOD-38688 | biostudies-arrayexpress
2010-10-08 | E-GEOD-13721 | biostudies-arrayexpress
2011-09-05 | GSE24187 | GEO
2011-09-05 | GSE24186 | GEO
2011-09-04 | E-GEOD-24187 | biostudies-arrayexpress
2011-09-04 | E-GEOD-24186 | biostudies-arrayexpress
2018-10-24 | PXD002633 | Pride
2012-01-11 | E-GEOD-34945 | biostudies-arrayexpress
| S-EPMC5108468 | biostudies-literature
2015-09-20 | E-GEOD-64836 | biostudies-arrayexpress